Radioiodinated antibody targeting of the HER-2/neu oncoprotein

被引：19
|
作者：
Xu, FJ
Yu, YH
Bae, DS
Zhao, XG
Slade, SK
Boyer, CM
Bast, RC
Zalutsky, MR
机构：
[1] UNIV TEXAS,MD ANDERSON CANCER CTR,DIV MED,HOUSTON,TX 77030
[2] DUKE UNIV,MED CTR,DEPT RADIOL,DURHAM,NC 27710
[3] DUKE UNIV,MED CTR,DEPT PATHOL,DURHAM,NC 27710
来源：
NUCLEAR MEDICINE AND BIOLOGY | 1997年 / 24卷 / 05期
关键词：
c-erbB-2 (HER-2/neu); ovarian cancer; monoclonal antibody; radioiodination; tumor;
D O I：
10.1016/S0969-8051(97)00065-6
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
The HER-2/neu oncogene encodes a 185 kDa phosphoglycoprotein that is overexpressed in breast, ovarian and other cancers. Seven monoclonal antibodies reactive with this oncoprotein were labeled with I-131. In vitro experiments with SKOv3 9002-18 cells determined binding affinity, internalization and degradation. The biodistribution of these antibodies in comparison to I-125-labeled nonspecific antibody was measured in athymic mice with SKOv3 9002-18 ovarian carcinoma xenografts. Antibody 520C9 exhibited the highest and most specific retention in tumor, peaking at 17.4 +/- 5.6% ID/g at 24 h. (C) 1997 Elsevier Science Inc.
引用
收藏
页码：451 / 459
页数：9
相关论文
共 50 条
  • [1] RADIOLABELED ANTIBODY TARGETING OF THE HER-2/NEU ONCOPROTEIN
    DESANTES, K
    SLAMON, D
    ANDERSON, SK
    SHEPARD, M
    FENDLY, B
    MANEVAL, D
    PRESS, O
    CANCER RESEARCH, 1992, 52 (07) : 1916 - 1923
  • [2] Radioiodinated antibody targeting of the HER-2/neu oncoprotein:: Effects of labeling method on cellular processing and tissue distribution
    Zalutsky, MR
    Xu, FJ
    Yu, Y
    Foulon, CF
    Zhao, XG
    Slade, SK
    Affleck, DJ
    Bast, RC
    NUCLEAR MEDICINE AND BIOLOGY, 1999, 26 (07) : 781 - 790
  • [3] Monoclonal antibody to HER-2/neu receptor enhances radiosensitivity of esophageal cancer cell lines expressing HER-2/neu oncoprotein
    Sato, S
    Kajiyama, Y
    Sugano, M
    Iwanuma, Y
    Sonoue, H
    Matsumoto, T
    Sasai, K
    Tsurumaru, M
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 61 (01): : 203 - 211
  • [4] Circulating levels of HER-2/neu oncoprotein in breast cancer
    Molina, Rafael
    Escudero, Jose M.
    Munoz, Montse
    Auge, Jose M.
    Filella, Xavier
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2012, 50 (01) : 5 - 21
  • [5] HER-2/neu (657-665) represents an immunogenic epitope of HER-2/neu oncoprotein with potent antitumor properties
    Gritzapis, Angelos D.
    Fridman, Arthur
    Perez, Sonia A.
    La Monica, Nicola
    Papamichail, Michael
    Aurisicchio, Luigi
    Baxevanis, Constantin N.
    VACCINE, 2009, 28 (01) : 162 - 170
  • [6] Transcriptional targeting of the HER-2/neu oncogene
    Wang, SC
    Hung, MC
    DRUGS OF TODAY, 2000, 36 (12): : 835 - 843
  • [7] HER-2/NEU ONCOPROTEIN AS A PROGNOSTIC FACTOR IN BREAST-CANCER
    TOIKKANEN, S
    JOENSUU, H
    JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (11) : 1817 - 1817
  • [8] Targeting HER-2/neu with antirat Neu virosomes for cancer therapy
    Waelti, E
    Wegmann, N
    Schwaninger, R
    Wetterwald, A
    Wingenfeld, C
    Rothen-Rutishauser, B
    Gimmi, CD
    CANCER RESEARCH, 2002, 62 (02) : 437 - 444
  • [9] Targeting Her-2/neu in breast cancer: As easy as this!
    Azim, Hamdy
    Azim, Hatem A., Jr.
    ONCOLOGY, 2008, 74 (3-4) : 150 - 157
  • [10] Discontinuous antisense targeting HER-2/neu oncogene
    Perlman, JI
    Stein, S
    Leibowitz, MJ
    MOLECULAR BIOLOGY OF THE CELL, 2002, 13 : 159A - 159A
12345